Kaouthar Louati | Neuroscience | Excellence in Research Award
Dr Kaouthar Louati, University of Monastir, Tunisia
Dr. Kaouthar Louati is a distinguished researcher and analytical chemist ๐๐งช with a doctoral degree in Analytical Chemistry from the University of Monastir, Tunisia ๐น๐ณ. She has made substantial contributions to pharmaceutical sciences through over 15 high-impact publications ๐, two book contributions ๐, and collaborative projects in Tunisia and the UK ๐ฌ๐ง. Her work focuses on toxicoproteomics, redox proteomics, and stability studies of pharmaceuticals ๐. Dr. Louati is affiliated with prestigious institutions including the University of Nottingham, Habib Bourguiba University Hospital, and multiple pharmaceutical laboratories ๐ฅ๐ฌ. Known for her meticulous method validation, drug impurity analysis, and environmental toxicology studies ๐ฟโ๏ธ, she has emerged as a key figure in analytical method development and toxicological risk assessment. With deep academic commitment and a passion for pharmaceutical innovation ๐ก, she continues to impact the global scientific community and serves as a role model for women in STEM ๐ฉโ๐ฌ๐.
Publication Profile
Education
Dr. Louatiโs academic journey is rooted in excellence ๐. She earned her Doctorate in Analytical Chemistry (2019โ2024) ๐งช from the University of Monastir, Tunisia, with very honorable distinction ๐. Previously, she completed a Masterโs in Medicamentsโ Research and Development (2009โ2010) ๐งฌ and a Diploma in Doctor of Pharmacy (2008โ2009), both with high honors ๐ . Her early academic path included a Diploma in Pharmacy (2002โ2007) with a very good grade ๐งโโ๏ธ and a Mathematics Baccalaureate (2002) with very honorable mention ๐ง โโ. Throughout her education, she displayed strong scientific aptitude, particularly in pharmaceutical formulation, analytical chemistry, and medical science fundamentals ๐๐. This rich academic foundation positioned her to excel in multidisciplinary pharmaceutical research, bridging clinical applications with laboratory innovation ๐งซ๐.
Experience
Dr. Louati has extensive experience in academia, hospitals, and the pharmaceutical industry ๐ฅ๐ญ. Since 2020, she has served as a Doctor Pharmacist and Associate Researcher at the University of Monastirโs Laboratory of Pharmacology and Drug Development ๐ฌ, and at the Habib Bourguiba University Hospital in both the pharmaceutical and pathological anatomy departments ๐งโโ๏ธ๐งซ. She also contributed internationally at the University of Nottingham and Royal Derby Hospital, UK (2020โ2023) ๐ฌ๐ง. From 2010 to 2015, she worked in UNIMED and PHARMACARE Laboratories, where she developed generic drugs, validated analytical methods, and ensured product compliance with international pharmacopeias ๐๐. Her expertise spans method validation (ICH Q2R1), stress testing, impurity profiling, and regulatory documentation โ๏ธ๐. Her collaborative approach and technical leadership across diverse settings underscore her excellence as both a researcher and pharmaceutical scientist ๐๐งช.
Awards and Honors
Dr. Kaouthar Louati has earned academic distinction throughout her career, including โVery Honorableโ mentions for both her doctoral and masterโs studies ๐ ๐. She was recognized for producing highly cited research and has published over 15 peer-reviewed articles and 2 books in respected international journals and editions ๐๐. Her contributions to method development, toxicological evaluation, and environmental health have received national and international attention ๐งฌ๐. Her scientific rigor earned her opportunities to collaborate with global institutions such as the University of Nottingham, reflecting peer recognition and trust in her expertise ๐ค๐ฌ. Her work on toxicoproteomics and pharmaceutical impurities has made significant impacts on public health research and regulatory science ๐ก๏ธโ๏ธ. Dr. Louatiโs continued academic excellence, innovation, and mentorship potential position her as a prime candidate for the Best Researcher Award ๐๐๏ธ.
Research Focus
Dr. Louatiโs research is at the forefront of analytical chemistry, toxicoproteomics, and pharmaceutical sciences ๐๐งช. She focuses on validating and developing robust analytical methods to detect drug impurities, residual solvents, and degradation products, essential for drug stability and safety studies ๐๐. Her work in toxicoproteomics includes assessing oxidative stress and protein damage induced by environmental toxins like pesticides using cutting-edge techniques like Nano-UHPLC-MS/MS and 2D-SDS-PAGE ๐ฟ๐งฌ. She also pioneers method development for anti-epileptic drug monitoring and anabolic steroid detection for doping control ๐ง ๐ช. Her integration of redox biology and pharmacological analytics strengthens both environmental health surveillance and clinical pharmacology ๐๐ฅ. Dr. Louatiโs unique blend of expertise bridges fundamental research with real-world applications, significantly contributing to public health, pharmacovigilance, and regulatory standards ๐๐.